Evogene financial statements

에보진NASDAQ:EVGN · Nasdaq · Healthcare · sector #16
$0.4237+4.93%
2026-10-06 close · prelim

Evogene's published financial data is dated 2026-10-04. 2024 revenue was $9M. 2024 operating profit was −$22M.

Reported results

Evogene notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q